Jonathan Himmelfarb

Jonathan Himmelfarb

Company: University of Washington

Job title: Professor of Medicine


Developing Novel Biomarkers & Optimum Endpoints Beyond 90-Day Mortality to Improve Clinical Progress in AKI 12:30 pm

Implementing GFR, Albuminuria, and patient-reported outcomes as endpoints Should we move away from 90-day mortality outcomes? Reflecting on clinical setbacks: considering alternative outcomes to monitor efficacy more effectivelyRead more

day: Seminar Day

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.